Embolx Revenue and Competitors
Estimated Revenue & Valuation
- Embolx's estimated annual revenue is currently $5.3M per year.
- Embolx's estimated revenue per employee is $251,000
Employee Data
- Embolx has 21 Employees.
- Embolx grew their employee count by 5% last year.
Embolx's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Finance | Reveal Email/Phone |
2 | Northeast Regional Manager | Reveal Email/Phone |
3 | Marketing Manager | Reveal Email/Phone |
4 | Medical Consultant | Reveal Email/Phone |
5 | President & CEO | Reveal Email/Phone |
Embolx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Embolx?
Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues.
keywords:N/AN/A
Total Funding
21
Number of Employees
$5.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 21 | -9% | N/A |
#2 | N/A | 21 | 0% | N/A |
#3 | $2.1M | 21 | 11% | N/A |
#4 | $4.3M | 21 | 5% | N/A |
#5 | $4M | 21 | -9% | N/A |